OBJECTIVE: Traditionally, the diagnosis of pleural mesothelioma is based on histological material. Minimally invasive effusion cytology specimens are an alternative that, like biopsies, require ancillary analyses. Validation of immunohistochemical (IHC) analyses on cytology, including the surrogate markers for molecular alterations BAP1 and MTAP, is of interest.METHODS: IHC for eight different markers was performed on 59 paired formalin-fixed, paraffin-embedded pleural biopsies and pleural effusion cell blocks with mesothelioma. Immunoreactivity in ≥10% of tumour cells was considered positive/preserved. The concordance between histological and cytological materials was assessed.RESULTS: The overall percentage of agreement between the histol...
Mesothelioma arises from the surface serosal cells lining the pleural, peritoneal, and pericardial c...
Background and aim: malignant pleural mesothelioma (MPM) is a rare, asbestos-related tumor, extremel...
Objective The aim of this study was to investigate the utility of BRCA1-associated protein-1 (BAP1),...
Cytology effusions are often the only material available for diagnosing malignant pleural mesothelio...
Malignant mesothelioma is a rare malignancy with a poor prognosis whose development is related to as...
Pleural effusions are among the first clinical manifestations of malignant pleural mesothelioma (MPM...
Background: Mesothelioma is a rare but aggressive malignancy with therapeutic options that are gener...
BACKGROUND: The distinction of benign from malignant mesothelial proliferations in cytologic specim...
The aim of the study was to establish in a prospective and blinded manner the diagnostic yield of mo...
BACKGROUND: Malignant mesothelioma (MM) is a therapy-resistant tumor, often causing an effusion. Dru...
Malignant pleural mesothelioma (MPM) is a deadly cancer that is caused by asbestos exposure and that...
International audienceSTUDY OBJECTIVE: The aim of the study was to assess diagnosis value of tumor m...
Introduction: Although cytological examination helps in diagnosis of malignancy in serous effusion, ...
In this study, we aimed to examine the clinical value of the pleural effusion (PE) biomarkers, solub...
Mesothelioma arises from the surface serosal cells lining the pleural, peritoneal, and pericardial c...
Background and aim: malignant pleural mesothelioma (MPM) is a rare, asbestos-related tumor, extremel...
Objective The aim of this study was to investigate the utility of BRCA1-associated protein-1 (BAP1),...
Cytology effusions are often the only material available for diagnosing malignant pleural mesothelio...
Malignant mesothelioma is a rare malignancy with a poor prognosis whose development is related to as...
Pleural effusions are among the first clinical manifestations of malignant pleural mesothelioma (MPM...
Background: Mesothelioma is a rare but aggressive malignancy with therapeutic options that are gener...
BACKGROUND: The distinction of benign from malignant mesothelial proliferations in cytologic specim...
The aim of the study was to establish in a prospective and blinded manner the diagnostic yield of mo...
BACKGROUND: Malignant mesothelioma (MM) is a therapy-resistant tumor, often causing an effusion. Dru...
Malignant pleural mesothelioma (MPM) is a deadly cancer that is caused by asbestos exposure and that...
International audienceSTUDY OBJECTIVE: The aim of the study was to assess diagnosis value of tumor m...
Introduction: Although cytological examination helps in diagnosis of malignancy in serous effusion, ...
In this study, we aimed to examine the clinical value of the pleural effusion (PE) biomarkers, solub...
Mesothelioma arises from the surface serosal cells lining the pleural, peritoneal, and pericardial c...
Background and aim: malignant pleural mesothelioma (MPM) is a rare, asbestos-related tumor, extremel...
Objective The aim of this study was to investigate the utility of BRCA1-associated protein-1 (BAP1),...